Literature DB >> 29066639

Idiopathic catastrophic thrombosis with happy ending.

Julia Heid1, Andreas Greinacher2, Hugo A Katus1, Oliver J Müller1,3.   

Abstract

A 59-year-old male patient suffered three life-threatening instent thromboses after an initial resuscitation due to an ST-segment elevation myocardial infarction of the anterior cardiac wall. With a high-risk profile for heparin-induced thrombocytopenia (HIT), he was placed on argatroban after the second reinfarction. Under this apparently appropriate treatment, a third reinfarction occurred, and the patient had to undergo high-risk cardiac bypass surgery. Later on, a deep vein thrombosis and an intracardiac thrombus formed. Despite a positive screening test for HIT and a single positive result in the heparin-induced platelet aggregation test, we are not convinced that HIT was the only underlying cause for this 'catastrophic thrombotic syndrome'. We speculate that a massive generation of thrombin, reflected in consistently high D dimers and the need of copious amounts of a direct thrombin inhibitor, triggered the set of events. With this case report, we want to raise awareness for cardiac complications in patients with complex clotting disorders and share our experience in the diagnostic and therapeutic management of such an unusual scenario. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adult intensive care; clinical diagnostic tests; interventional cardiology; ischaemic heart disease; venous thromboembolism

Mesh:

Substances:

Year:  2017        PMID: 29066639      PMCID: PMC5665346          DOI: 10.1136/bcr-2017-221194

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  How I treat catastrophic thrombotic syndromes.

Authors:  Thomas L Ortel; Doruk Erkan; Craig S Kitchens
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

Review 2.  CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.

Authors:  Andreas Greinacher
Journal:  N Engl J Med       Date:  2015-07-16       Impact factor: 91.245

Review 3.  Thrombotic storm: when thrombosis begets thrombosis.

Authors:  C S Kitchens
Journal:  Am J Med       Date:  1998-04       Impact factor: 4.965

Review 4.  Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Authors:  Adam Cuker; Phyllis A Gimotty; Mark A Crowther; Theodore E Warkentin
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

5.  Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.

Authors:  George Palatianos; Alkiviadis Michalis; Petros Alivizatos; Stavroula Lacoumenda; Stefanos Geroulanos; Andreas Karabinis; Eugenia Iliopoulou; Giannoula Soufla; Chryso Kanthou; Mazen Khoury; Petros Sfyrakis; George Stavridis; George Astras; Maria Vassili; Christina Antzaka; Katerina Marathias; Ioannis Kriaras; Androniki Tasouli; Kyrillos Papadopoulos; Marina Katafygioti; Nikoletta Matoula; Antonios Angelidis; Euthemia Melissari
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

6.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

7.  Apparent argatroban resistance in a patient with elevated factor VIII levels.

Authors:  Dina M Kennedy; Cesar Alaniz
Journal:  Ann Pharmacother       Date:  2013-06-04       Impact factor: 3.154

8.  Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.

Authors:  Thi-Huong Nguyen; Nikolay Medvedev; Mihaela Delcea; Andreas Greinacher
Journal:  Nat Commun       Date:  2017-05-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.